These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder. Pollack MH J Clin Psychiatry; 2001; 62 Suppl 12():24-9. PubMed ID: 11430615 [TBL] [Abstract][Full Text] [Related]
18. Treatment of anxiety disorders in the Finnish general population. Sihvo S; Hämäläinen J; Kiviruusu O; Pirkola S; Isometsä E J Affect Disord; 2006 Nov; 96(1-2):31-8. PubMed ID: 16797721 [TBL] [Abstract][Full Text] [Related]
19. Comorbidity and boundaries of affective disorders with anxiety disorders and substance misuse: results of an international task force. Merikangas KR; Angst J; Eaton W; Canino G; Rubio-Stipec M; Wacker H; Wittchen HU; Andrade L; Essau C; Whitaker A; Kraemer H; Robins LN; Kupfer DJ Br J Psychiatry Suppl; 1996 Jun; (30):58-67. PubMed ID: 8864150 [TBL] [Abstract][Full Text] [Related]
20. Benzodiazepines and the treatment of anxiety disorders in patients with comorbid alcohol and/or drug abuse. Sher L Aust N Z J Psychiatry; 2008 Feb; 42(2):170-1. PubMed ID: 18354817 [No Abstract] [Full Text] [Related] [Next] [New Search]